Lubiprostone bulk supplier for pharma manufacturers

Lubiprostone Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 8 mcg, 24 mcg

Reference Brands: Amitiza (USA/EU)

Category: Gastrointestinal Drugs

Lubiprostone is used to treat chronic idiopathic constipation (CIC), constipation in patients using opioids (opioid‑induced constipation, OIC), and irritable bowel syndrome with constipation (IBS‑C) in adult women. It works by activating chloride (ClC‑2) channels in the intestinal lining, which increases fluid secretion into the intestines, softens stools, improves motility, and promotes spontaneous bowel movements. Lubiprostone is available in Capsules and strengths such as 8 mcg, 24 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lubiprostone is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Lubiprostone can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Lubiprostone is used to treat chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation.

Lubiprostone is a bicyclic fatty acid derivative that activates chloride channels in the intestine, increasing fluid secretion and easing bowel movements.

The trade name is Amitiza.

Amitiza is manufactured by Takeda Pharmaceuticals.

The generic name is lubiprostone.

The brand name is Amitiza.

It is manufactured in the United States by Takeda Pharmaceuticals.

Yes, Lubiprostone is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Lubiprostone is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Crofelemer

Strength:
125 mg

Form: Tablets

Reference Brands: Fulyzaq (USA)

View Details
Naloxegol Oxalate

Strength:
12.5 mg, 25 mg

Form: Tablets

Reference Brands: Movantik (USA), Moventig (EU)

View Details
Methscopolamine Bromide

Strength:
2.5 mg, 5 mg

Form: Tablets

Reference Brands: Pamine (USA)

View Details
Linaclotide

Strength:
72 mcg, 145 mcg, 290 mcg

Form: Capsules

Reference Brands: Linzess (USA), Constella (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.